GSK Consumer Q3 PAT seen up 11.7% YoY to Rs. 182.8 cr: Kotak

GSK Pharma | Company reported lower profit at Rs 76.5 crore in Q2FY21 compared to Rs 502.7 crore, revenue fell to Rs 879 crore from Rs 882 crore YoY.

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Kotak has come out with its third quarter (October-December’ 18) Earnings estimates for the Consumer Staples sector. The brokerage house expects GSK Consumer to report net profit at Rs. 182.8 crore up 11.7% year-on-year (down 33.6% quarter-on-quarter).

Net Sales are expected to increase by 7.1 percent Y-o-Y (down 12.6 percent Q-o-Q) to Rs. 1,111.6 crore, according to Kotak.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 11.3 percent Y-o-Y (down 34.7 percent Q-o-Q) to Rs. 231 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More